Results 21 to 30 of about 64,817,182 (291)

The Alzheimer variant of Lewy body disease: A pathologically confirmed case-control study [PDF]

, 2005
The objective of the study was to identify clinical features that distinguish patients with dementia with Lewy bodies (DLB), who were classified as Alzheimer's disease ( AD) patients, from patients with AD.
Müller, U., Neumann, M., Kretzschmar, H., Perneczky, R., Kurz, A., Förstl, Hans, Mösch, D., Busch, R., Perneczky, R.;Mösch, D.;Neumann, M.;Kretzschmar, H.;Müller, U.;Busch, R.;Förstl, H.;Kurz, A., Perneczky, R;Mosch, D;Neumann, M;Kretzschmar, H;Müller, U;Busch, R;Förstl, H;Kurz, A   +9 more
core   +1 more source

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies [PDF]

, 2007
Background: The measurement of biomarkers in cerebrospinal fluid (CSF) has gained increasing acceptance in establishing the diagnosis of some neurodegenerative diseases.
Steinacker, Petra, Brechlin, Peter, Bahn, Erik, Bibl, Mirko, Locascio, Joseph J., Kretzschmar, Hans A., Mollenhauer, Brit, Trenkwalder, Claudia, Schlossmacher, Michael G., Poser, Sigrid, Otto, Markus, Wiltfang, Jens   +11 more
core   +1 more source

Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium

Frontiers in Neurology, 2022
The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLBs) and ...
Gregory D. Scott, Gregory D. Scott, Moriah R. Arnold, Thomas G. Beach, Christopher H. Gibbons, Anumantha G. Kanthasamy, Russell M. Lebovitz, Afina W. Lemstra, Leslie M. Shaw, Charlotte E. Teunissen, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Angela S. Taylor, Todd C. Graham, Bradley F. Boeve, Stephen N. Gomperts, Neill R. Graff-Radford, Charbel Moussa, Kathleen L. Poston, Liana S. Rosenthal, Marwan N. Sabbagh, Ryan R. Walsh, Miriam T. Weber, Melissa J. Armstrong, Jee A. Bang, Andrea C. Bozoki, Kimiko Domoto-Reilly, John E. Duda, John E. Duda, Jori E. Fleisher, Douglas R. Galasko, James E. Galvin, Jennifer G. Goldman, Samantha K. Holden, Lawrence S. Honig, Daniel E. Huddleston, James B. Leverenz, Irene Litvan, Carol A. Manning, Karen S. Marder, Alexander Y. Pantelyat, Victoria S. Pelak, Douglas W. Scharre, Sharon J. Sha, Holly A. Shill, Zoltan Mari, Joseph F. Quinn, Joseph F. Quinn, David J. Irwin, David J. Irwin, David J. Irwin, David J. Irwin   +54 more
doaj   +1 more source

Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience [PDF]

, 2008
Background: Dementia results from heterogeneous diseases of the brain. Mixed disease forms are increasingly recognized. Methods: We performed a survey within brain banks of BrainNet Europe to estimate the proportion of mixed disease forms underlying ...
Gelpi, Ellen, Kretzschmar H, Alafuzoff, Irina, Alafuzoff I, Budka H., Nagy, Zoltan, Seilhean, Danielle, Ferrer I, Arzberger, Thomas, Al-Sarraj, Safa, Gelpi E, Kovacs, Gabor G., Kretzschmar, Hans, Soininen, Hilkka, Troakes, Claire, Nagy Z, Capellari, Sabina, Seilhean D, Kövari V, Budka, Herbert, Al Sarraj S, Troakes C, Alafuzoff, Irina,, Arzberger T, Ferrer, Isidro, Bogdanovic, Nenad, Bogdanovic N, Kovari, Viktor, Soininen H, Parchi, Piero, Kovacs GG   +30 more
core   +1 more source

A new visual rating scale for Ioflupane imaging in Lewy body disease

NeuroImage: Clinical, 2018
Background: Dopaminergic loss on 123I-Ioflupane brain imaging is a recognised biomarker for dementia with Lewy bodies. It is usually assessed using a visual rating scale developed for Parkinson's disease, which may not be optimal for dementia with Lewy ...
Jim J. Lloyd, George Petrides, Paul C. Donaghy, Sean J. Colloby, Johannes Attems, John T. O'Brien, Gemma Roberts, Alan J. Thomas   +7 more
doaj   +1 more source

Analytical performance and clinical utility of the INNOTEST (R) PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies [PDF]

, 2006
Background: Total tau (T-tau) and beta-amyloid((1-42)) (A beta(1-42)) levels in cerebrospinal fluid (CSF) can differentiate Alzheimer's disease (AD) from normal aging or depressive pseudo-dementia.
Bläser, Miriam, Blennow, Kaj,, Vanderstichele, Hugo, Bürger, Katharina, Karen De Vreese, Anari, Lessia, Olsson, Annika Ohrfelt, Miriam Bläser, OLSSON AO, BLASER M, Eugeen Vanmechelen, Harald Hampel, DiLuca, Monica, BURGER K, ANDREASEN N, Christian Sindic, Niels Andreasen, Vanmechelen, Eugeen, Frank Hulstaert, PARNETTI L, LANARI A, VANDERSTICHELE H, Andreasen, Niels, DILUCA M, Katharina Bürger, Pottel, Hans, Öhrfelt Olsson, Annika,, Lanari, Alessia, Parnetti, Lucilla, DE VREESE K, Sindic, Christian, Hulstaert, Frank, Buerger, Katharina, PADOVANI, Alessandro, Monica DiLuca, De Vreese, Karen, Kaj Blennow, Ivanoiu, Adrian, POTTEL H, Padovani, Allesandro, BLENNOW K, Lucilla Parnetti, Annika Ohrfelt Olsson, Hans Pottel, HAMPEL H, Alessia Lanari, Allesandro Padovani, Hampel, Harald, Hugo Vanderstichele, SINDIC C, IVANOIU A, VANMECHELEN E., Blennow, Kaj, HULSTAERT F, Adrian Ivanoiu, Blennow, K, Lanari, A, Parnetti, L, Hampel, H, De, Vreese K, Andreasen, N,, Sindic, C, Vanderstichele, H, Ivanoiu, A, Buerger, K   +64 more
core   +2 more sources

Young-Onset Dementia with Lewy Bodies

Case Reports in Neurology, 2018
Young-onset (< 65 years) dementia is a challenging clinical problem. A 61-year-old man visited our clinic because of a 2-year history of mild cognitive impairment of the executive disorder type.
Yosuke Aiba, Ryuji Sakakibara, Tsuyoshi Ogata, Ayako Iimura, Keiichiro Terayama, Keiko Suzuki, Shuichi Katsuragawa, Yuuki Kato, Fuyuki Tateno, Hitoshi Terada, Tsutomu Inaoka, Tomoya Nakatsuka   +11 more
doaj   +1 more source

Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia. [PDF]

, 2012
The prevalence of Parkinson's disease (PD) increases with age. Up to 50% of PD show cognitive decline in terms of a mild cognitive impairment already in early stages that predict the development of dementia, which can occur in up to 80% of PD patients ...
Hans A Kretzschmar, Manuela Neumann, Hans A. Kretzschmar (46374), Neumann, Manuela, Soininen, H., Saskia Tawfik, Hengerer, B., Herukka, Sanna-Kaisa, Kulaksiz, H., Ferger, B., Tawfik, Saskia, Steinacker, Petra, Steinacker, P., Lenter, M., Manuela Neumann (120819), Jesse, S., Lehnert, S., Kulaksiz, Hasan, Bastian Hengerer, Neumann, M., Christine A F von Arnim, Markus Otto (120832), Otto, Markus, Christine A. F. von Arnim (120817), Lucilla Parnetti (120805), Sarah Jesse (120792), Parnetti, Lucilla, Hilkka Soininen, Jahn, Olaf, Wiltfang, Jens, Hilkka Soininen (120808), Jahn, O., Petra Steinacker (120812), Tumani, Hayrettin, Lenter, Martin, Kretzschmar, Hans A., Tumani, H., Otto, M., Boris Ferger, Hayrettin Tumani, Martin Lenter, Hengerer, Bastian, Saskia Tawfik (120814), Wiltfang, J., Olaf Jahn, Lucilla Parnetti, Soininen, Hilkka, Bastian Hengerer (120831), Sanna-Kaisa Herukka, Olaf Jahn (120801), Martin Lenter (120825), von Arnim, Christine A. F., Markus Otto, von Arnim, C., Stefan Lehnert, Petra Steinacker, Hayrettin Tumani (120815), Arnim, Christine A. F. von, Hasan Kulaksiz, Ferger, Boris, Stefan Lehnert (120797), Jens Wiltfang (44073), Sanna-Kaisa Herukka (120810), Jens Wiltfang, Kretschmar, H., Parnetti, L., Hasan Kulaksiz (120823), Boris Ferger (120827), Herukka, S., Jesse, Sarah, Tawfik, S., Lehnert, Stefan, Sarah Jesse   +72 more
core   +1 more source

Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021
Dementia with Lewy bodies (DLB) research has seen a significant growth in international collaboration over the last three decades. However, researchers face a challenge in identifying large and diverse samples capable of powering longitudinal studies and
Fabrizia D'Antonio, Joseph P.M. Kane, Agustin Ibañez, Simon J.G. Lewis, Richard Camicioli, Huali Wang, Yueyi Yu, Jing Zhang, Yong Ji, Miguel Germán Borda, Rukmini Mridula Kandadai, Claudio Babiloni, Laura Bonanni, Manabu Ikeda, Bradley F. Boeve, James B. Leverenz, Dag Aarsland, the ISTAART Lewy body dementias Consortia Working Group   +17 more
doaj   +1 more source

Dementia with Lewy Bodies.

Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2000
Dementia with Lewy bodies (DLB), the second most frequent cause of primary degenerative dementias following Alzheimer's disease, has been increasingly recognized since the proposal of the consensus name and clinical diagnostic criteria. Although DLB overlaps in clinical, pathological, and genetic features with Alzheimer's disease and Parkinson's ...
openaire   +3 more sources